comparemela.com

Latest Breaking News On - Company reports of foreign issuer on form - Page 1 : comparemela.com

Quoin Pharmaceuticals Completes Merger and Will Commence Trading on Nasdaq Capital Market under Ticker Symbol QNRX Seite 1

29.10.2021 - Concomitant Investment from Altium Capital SecuredAshburn, VA, Oct. 28, 2021 (GLOBE NEWSWIRE) - Quoin Pharmaceuticals, Ltd., (NASDAQ: QNRX) (the “Company”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced . Seite 1

Michael myersExchange commissionExchange commission onCompany reports of foreign issuer on formQuoin pharmaceuticalsChief executive officerForeign issuer

Quoin Pharmaceuticals Completes Merger and Will Commence

Concomitant Investment from Altium Capital Secured.

San diegoUnited statesDenise carterJeff ramsonMichael myersAdi mohantyQuoin pharmaceuticals incExchange commission onCompany reports of foreign issuer on formEncellx incQuoin pharmaceuticals ltdCellect biotherapeutics ltdExchange commissionCompany annual report on formCellect biotechnology ltdQuoin pharmaceuticals

vimarsana © 2020. All Rights Reserved.